ARF Bio Yenilenebilir Enerji Üretim A.S. (IST:ARFYE)
Turkey · Delayed Price · Currency is TRY 30.58
-0.92 (-2.92%)
Last updated: Jun 3, 2026, 3:32 PM GMT+3
IST:ARFYE Income Statement
Financials in millions TRY. Fiscal year is January - December.
Millions TRY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 449.05 | 252.68 | 143.65 | 272.83 | 91.49 | 163.3 | |
Revenue Growth (YoY) | 64.59% | 75.90% | -47.35% | 198.20% | -43.97% | - |
Selling, General & Admin | 77 | 56.82 | 50.17 | 32.41 | 4.8 | 2.04 |
Other Operating Expenses | 322.75 | 179.9 | 91.94 | 155.93 | 72.58 | 29.49 |
Total Operating Expenses | 400.96 | 236.72 | 142.11 | 188.34 | 77.38 | 31.53 |
Operating Income | 48.09 | 15.96 | 1.54 | 84.48 | 14.11 | 131.77 |
Interest Expense | -145.35 | -156.88 | -68.69 | -24.35 | -10.86 | -4.87 |
Interest Income | 113.03 | 17.7 | 23.28 | 49.85 | 7.89 | 2.78 |
Net Interest Expense | -32.33 | -139.18 | -45.41 | 25.5 | -2.98 | -2.08 |
Currency Exchange Gain (Loss) | -22.45 | - | 33.66 | 2.32 | -0.11 | 0.6 |
EBT Excluding Unusual Items | -17.03 | -123.22 | -10.21 | 112.3 | 11.02 | 130.28 |
Gain (Loss) on Sale of Investments | -1.6 | -1.6 | - | - | - | -1.31 |
Pretax Income | -18.64 | -124.82 | -10.21 | 112.3 | 11.02 | 128.97 |
Income Tax Expense | 27.48 | -3.36 | -18.18 | 11.1 | 6.01 | 27.15 |
Net Income | -46.12 | -121.46 | 7.97 | 101.19 | 5.01 | 101.82 |
Net Income to Common | -46.12 | -121.46 | 7.97 | 101.19 | 5.01 | 101.82 |
Net Income Growth | - | - | -92.13% | 1921.14% | -95.08% | 24098.24% |
Shares Outstanding (Basic) | 157 | 148 | 147 | 147 | 105 | 41 |
Shares Outstanding (Diluted) | 157 | 148 | 147 | 147 | 105 | 41 |
Shares Change (YoY) | 6.56% | 0.54% | - | 40.00% | 155.44% | 1959.99% |
EPS (Basic) | -0.29 | -0.82 | 0.05 | 0.69 | 0.05 | 2.47 |
EPS (Diluted) | -0.29 | -0.82 | 0.05 | 0.69 | 0.05 | 2.47 |
EPS Growth | - | - | -92.13% | 1343.68% | -98.08% | 1074.68% |
Free Cash Flow | - | - | -28.56 | 25.11 | -24.44 | -208.03 |
Free Cash Flow Per Share | - | - | -0.19 | 0.17 | -0.23 | -5.05 |
Profit Margin | -10.27% | -48.07% | 5.55% | 37.09% | 5.47% | 62.35% |
Free Cash Flow Margin | - | - | -19.88% | 9.21% | -26.72% | -127.39% |
EBITDA | 86.84 | 52.57 | 38.47 | 102.28 | 20.68 | 135.25 |
EBITDA Margin | 19.34% | 20.80% | 26.78% | 37.49% | 22.60% | 82.82% |
D&A For EBITDA | 38.75 | 36.61 | 36.94 | 17.8 | 6.57 | 3.48 |
EBIT | 48.09 | 15.96 | 1.54 | 84.48 | 14.11 | 131.77 |
EBIT Margin | 10.71% | 6.32% | 1.07% | 30.96% | 15.42% | 80.69% |
Effective Tax Rate | - | - | - | 9.89% | 54.57% | 21.05% |